Quantcast

Latest Melanoma Stories

2014-09-29 23:03:24

In May, the website for mesothelioma patients and their families reported on the first mesothelioma patient accepted into a U.K. clinical trial of the drug, which was recently approved by the FDA for use in treating advanced melanoma patients. New York, NY (PRWEB) September 29, 2014 MesotheliomaHelp.org is calling attention today to the U.S. Food and Drug Administration’s accelerated approval of Keytruda (pembrolizumab; MK-3475) for the treatment of patients with advanced or surgically...

2014-09-29 08:30:43

- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept. 29, 2014 /PRNewswire/ -- Final results from a Phase 2 trial of binimetinib in patients with advanced NRAS mutant melanoma were presented today at the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid, Spain. Invented by Array BioPharma Inc. (NASDAQ: ARRY) and licensed to Novartis in 2010, binimetinib is a small molecule selective inhibitor of the kinases MEK1 and MEK2....

2014-09-25 23:03:26

The North American Dermatology treatment devices market report defines and segments the concerned market in North America, with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/north-america-dermatology-treatment-devices-4338799582.html (PRWEB) September 25, 2014 The North American Dermatology treatment devices market report defines and segments the concerned market in North America, with analysis and forecast of revenue. The Dermatology treatment devices...

2014-09-18 12:29:43

The Highest Percentage of Non-Prescribers Anticipate Prescribing Tafinlar and Mekinist Within the Next One to Three Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that at one year post-launch in the United States, 54 percent of surveyed U.S. medical oncologists have prescribed GlaxoSmithKline's BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or metastatic melanoma, compared with 49...

2014-09-18 12:27:56

LONDON, Sept. 18, 2014 /PRNewswire/ -- This report gives you a new and unique way of stratifying and analyzing the global melanoma pipeline and presents actionable analysis which allows you to discover:* Where the competition is; Which targets and companies are setting the path?* What is first-in-class in the melanoma pipeline?* Is First-in-Class the Best-in-Class?* Indication expansion opportunities* Drug repositioning opportunities* Which pathways are targeted, by what and how?*...

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

soldier skin cancer
2014-09-16 03:30:15

Wayne Wood, Vanderbilt University Medical Center Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer. In a retrospective study of about 200 veterans seen at the post-deployment clinic of the Tennessee Valley Healthcare System of the U.S. Department of Veterans Affairs, researchers from Vanderbilt University Medical Center and the Tennessee Valley Healthcare System found that 62 percent of...

2014-09-15 23:01:41

The study revealed that Sildenafil (Viagra) is associated with an 84 percent increased risk of the most deadly form of skin cancer. Port Washington, New York (PRWEB) September 15, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured by medications reports that a recent study found that use of Viagra (sildenafil citrate), which is also sold under the brand Revatio, is tied to increased risks for melanoma. The...

2014-09-11 23:04:00

A Recently Published Study Found That Men Who Take Sildenafil (Viagra) Have An 84 Percent Risk of Developing Invasive Melanoma. New York NY (PRWEB) September 11, 2014 The Oliver Law Group P.C. reports that a recently published study has found that the use of Sildenafil citrate, sold as Viagra and Revatio increases the risk for developing melanoma skin cancer. Research published in the June 2014 issue of JAMA Internal Medicine showed men who said they used sildenafil, the generic name for...

2014-09-10 12:28:10

The Emergence of Keytruda--the First PD-1 Inhibitor Approved in the U.S.--is a Significant Milestone in Oncology, According to Decision Resources Group BURLINGTON, Mass., Sept. 10, 2014 /PRNewswire/ -- The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related